23 January 2017
News and Views
Links and Services
Metabolic syndrome increases the risk of liver fibrosis progression in chronic hep B
Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B, reports the latest issue of Alimentary Pharmacology & Therapeutics.
Metabolic syndrome is a known risk factor of cirrhosis in chronic hepatitis B (CHB).
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors